EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $643,500 | -9.7% | 82,500 | -4.7% | 0.00% | – |
| Q2 2023 | $712,718 | +19.2% | 86,600 | +5.0% | 0.00% | – |
| Q1 2023 | $598,125 | -18.3% | 82,500 | 0.0% | 0.00% | – |
| Q4 2022 | $731,775 | -27.5% | 82,500 | 0.0% | 0.00% | – |
| Q3 2022 | $1,010,000 | +3.5% | 82,500 | 0.0% | 0.00% | – |
| Q2 2022 | $976,000 | -37.8% | 82,500 | -0.0% | 0.00% | -100.0% |
| Q1 2022 | $1,569,000 | -28.2% | 82,504 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $2,185,000 | -35.4% | 82,304 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,381,000 | -27.5% | 82,304 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $4,662,000 | +34.9% | 82,304 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,457,000 | -39.7% | 82,304 | +0.6% | 0.00% | -33.3% |
| Q4 2020 | $5,735,000 | +149.9% | 81,800 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $2,295,000 | -4.7% | 81,800 | +0.5% | 0.00% | 0.0% |
| Q2 2020 | $2,408,000 | +78.4% | 81,400 | +19.5% | 0.00% | 0.0% |
| Q1 2020 | $1,350,000 | -32.4% | 68,100 | +1.0% | 0.00% | 0.0% |
| Q4 2019 | $1,996,000 | +32.6% | 67,400 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $1,505,000 | -8.1% | 66,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,638,000 | +1.2% | 66,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,619,000 | -42.9% | 66,200 | -46.9% | 0.00% | -50.0% |
| Q4 2018 | $2,835,000 | +36.0% | 124,600 | +90.2% | 0.00% | +100.0% |
| Q3 2018 | $2,084,000 | -10.0% | 65,500 | +1.4% | 0.00% | -50.0% |
| Q2 2018 | $2,315,000 | -17.5% | 64,600 | -23.7% | 0.00% | 0.0% |
| Q1 2018 | $2,807,000 | +114.4% | 84,670 | +98.8% | 0.00% | +100.0% |
| Q4 2017 | $1,309,000 | +30.8% | 42,600 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $1,001,000 | +43.0% | 41,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $700,000 | +29.6% | 41,700 | +72.3% | 0.00% | – |
| Q1 2017 | $540,000 | +37.4% | 24,200 | 0.0% | 0.00% | – |
| Q4 2016 | $393,000 | +20.6% | 24,200 | 0.0% | 0.00% | – |
| Q3 2016 | $326,000 | -19.5% | 24,200 | +45.8% | 0.00% | – |
| Q2 2016 | $405,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |